ArticlePharmacoEconomics2026

Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain.

Jonathan Briody et al.PubMed ↗Publisher ↗

No numbers read from the abstract.